Academic literature on the topic 'Prostate – Hypertrophy'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prostate – Hypertrophy.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Prostate – Hypertrophy"
Viennois, Emilie, Teresa Esposito, Julie Dufour, Aurélien Pommier, Stephane Fabre, Jean-Louis Kemeny, Laurent Guy, Laurent Morel, Jean-Marc Lobaccaro, and Silvère Baron. "Lxrα Regulates the Androgen Response in Prostate Epithelium." Endocrinology 153, no. 7 (April 30, 2012): 3211–23. http://dx.doi.org/10.1210/en.2011-1996.
Full textG., Diamantis, and Tode V. "Consideration of Drug Therapy in Benign Prostatic Hypertrophy." ARS Medica Tomitana 20, no. 3 (January 31, 2015): 129–34. http://dx.doi.org/10.2478/arsm-2014-0023.
Full textLi, Peng-Long, Hui Liu, Guo-Peng Chen, Ling Li, Hong-Jie Shi, Hong-Yu Nie, Zhen Liu, et al. "STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy." Hypertension 76, no. 4 (October 2020): 1219–30. http://dx.doi.org/10.1161/hypertensionaha.120.14752.
Full textMerendino, Rosaria Alba, Francesco Salvo, Antonella Saija, Giuseppe Di Pasquale, Antonio Tomaino, Paola Lucia Minciullo, Giuseppe Fraccica, and Sebastiano Gangemi. "Malondialdehyde in benign prostate hypertrophy: a useful marker?" Mediators of Inflammation 12, no. 2 (2003): 127–28. http://dx.doi.org/10.1080/0962935031000097745.
Full textNath, Chandan Kumar, Bhupen Barman, Pranjal Phukan, Stephen L. Sailo, Biswajit Dey, Indrajit Nath, and Purnima Rajkhowa. "Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma." Journal of Laboratory Physicians 12, no. 01 (March 2020): 44–48. http://dx.doi.org/10.1055/s-0040-1714195.
Full textPanarisi, S., M. Barbera, C. Cammarata, Q. Paola, G. Solazzo, F. Curto, and G. Curto. "Mini-invasive treatment of BPH with TUIP." Urologia Journal 65, no. 1 (February 1998): 137–39. http://dx.doi.org/10.1177/039156039806500135.
Full textGnana, Bhushan Kumar, and Sanjeeva Rao Matlapudi. "A comparative clinical evaluation of outcome of medical and surgical management of symptoms due to benign prostatic hyperplasia." International Surgery Journal 7, no. 9 (August 27, 2020): 3032. http://dx.doi.org/10.18203/2349-2902.isj20203789.
Full textZambolin, T., A. Cozzoli, G. Cancarini, G. P. Da Pozzo, C. Simeone, M. Scanzi, L. Tralce, F. Pagani, and S. Cosciani-Cunico. "Correlation between benign prostatic hypertrophy (BPH) and prostatic antigen (PSA)." Urologia Journal 59, no. 1_suppl (January 1992): 48–50. http://dx.doi.org/10.1177/039156039205901s15.
Full textZattoni, F. "Benign Prostatic Hypertrophy, Prostatic Cancer and Preneoplastic Lesions." Urologia Journal 59, no. 1 (February 1992): 58–60. http://dx.doi.org/10.1177/039156039205900113.
Full textKuriyama, Manabu. "Prostate-Specific Antigen in Prostate Cancer." International Journal of Biological Markers 1, no. 2 (May 1986): 67–76. http://dx.doi.org/10.1177/172460088600100202.
Full textDissertations / Theses on the topic "Prostate – Hypertrophy"
Chang, Ching-Jey George. "Prostate, benign hypertrophy and prostatic carcinoma - a study of cell biology of prostate and chemotherapy for prostatic hypertrophy and prostatic cancer /." The Ohio State University, 1994. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487856906256116.
Full textHerrera, Maria Lourdes C. "The expression of various growth factors in the normal human prostate, benign prostatic hyperplasia, and prostate carcinoma." Thesis, Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B1754628X.
Full textViennois, Emilie. "Impact d'une invalidation de LXRα sur la physiologie prostatique : un dialogue avec la signalisation androgénique." Phd thesis, Université Blaise Pascal - Clermont-Ferrand II, 2011. http://tel.archives-ouvertes.fr/tel-00841380.
Full textAmbrosini, Gina L. "Dietary risk factors for prostate cancer and benign prostatic hyperplasia." University of Western Australia. School of Population Health, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0135.
Full textSmith, Carolyn Margaret. "Characterisation of androgen metabolism and 5α-reductase activity in human prostate cells in vitro." Thesis, University College London (University of London), 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.308889.
Full textLima, Junior Mario Maciel de 1974. "Analise do perfil genotipico do sistema glutationa S-transferase e citocromo P450 na avaliação de susceptibilidade ao cancer de prostata e de prognostico." [s.n.], 2006. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310275.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-06T20:05:49Z (GMT). No. of bitstreams: 1 LimaJunior_MarioMacielde_M.pdf: 2114915 bytes, checksum: 56c9d6904dd7e0a16ab5565b0d280b7c (MD5) Previous issue date: 2006
Resumo: O câncer de próstata (CaP) é atualmente a neoplasia maligna mais prevalente no mundo, após os tumores de pele. A incidência dessa enfermidade tem crescido nas últimas décadas devido, principalmente; ao aumento da longevidade da população. Atualmente o CaP tem sido detectado em estágios menos avançados do que no passado. As melhorias dos métodos de diagnóstico contribuem para a detecção precoce dessa neoplasia. Os polimorfismos de genes que codificam enzimas envolvidas na metabolização de drogas e de xenobióticos, como as do sistema Glutationa S-transferase (GST) e Citocromo P450 (CYP), podem estar implicados no risco e prognóstico para neoplasias. Foram avaliados os genótipos de GSTT1, GSTM1, GSTP1, GSTO1 e CYP1A1 em 125 pacientes portadores de câncer de próstata e em 100 indivíduos com hiperplasia prostática benigna. Tempo e atividade ocupacional, tabagismo e outros dados relevantes da história natural da doença foram obtidas por meio de entrevistas. Não foram encontrados quaisquer associações entre os genótipos estudados e o risco de câncer de próstata, tanto avaliando os diferentes genótipos em separado como em combinações, através de análise de regressão logística uni ou multivariada. Não houve associação entre os genótipos estudados e fatores clínicos de risco para câncer de próstata ou quaisquer parâmetros de agressividade do tumor ao diagnóstico ou durante o seguimento. Nossos dados permitem concluir que os genótipos de GST e CYP1A1 não estão associados à susceptibilidade ao câncer de próstata ou à sua evolução na população brasileira estudada
Abstract: Prostate cancer is currently the most common malignancy worldwide, second only to skin tumors. The incidence of prostate cancer has risen dramatically over the last decade, more than can be explained just by the increase in longevity. It is also apparent that prostate cancer is now being detected at less advanced stages than in the past. Increased awareness of the disease and improved detection methods are thought to contribute to this earlier detection. The polymorphic inheritance of human drug-metabolizing enzymes, such as those encoded by the Glutathione-S-Transferase (GST) and the Cytochrome P450 (CYP) systems, may be implicated in both cancer risk and prognostic. We compared GSTT1, GSTM1, GSTO1, GSTP1 e CYP1A1 genotypes of 125 prostate cancer and 100 benign prostatic hyperplasia patients. Lifetime occupational history, cigarette-smoking, and other anamnestic data were obtained through interviews. None of the studied polymorphisms was found associated to prostate cancer risk either considered in separate or in combination, in uni ou multivariate regression logistic analysis. Also, there was no association between genotypes and possible clinical factors of risk, or any parameter of tumor agressiveness at diagnosis or during follow-up. Our data suggest that GST and CYP1A1 genotypes are not associated to the susceptibility to prostate cancer or its outcome in the Brazilian population
Mestrado
Clinica Medica
Mestre em Clinica Medica
Tsang, K. K. "Screening for benign prostatic hypertrophy." Thesis, University of Edinburgh, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.663068.
Full textCOEURDACIER, PIERRE. "Resultats a long terme de la chirurgie pour hypertrophie benigne de prostate." Rennes 1, 1993. http://www.theses.fr/1993REN1M027.
Full textAhouandjinou, Theodora Vignon. "Facteurs nutritionnels associés à la présence de lésions précancéreuses de la prostate (PIN) chez des hommes ayant une hypertrophie bénigne de la protestate." Master's thesis, Université Laval, 2008. http://hdl.handle.net/20.500.11794/19946.
Full textDUCHEMIN, JEAN-MICHEL. "Place de l'adenomectomie retro-pubienne dans le traitement chirurgical de l'hypertrophie benigne de la prostate." Amiens, 1994. http://www.theses.fr/1994AMIEM090.
Full textBooks on the topic "Prostate – Hypertrophy"
Ayurvedic managment of benign prostate hypertrophy. Colombo, Sri Lanka: S. Godage & Brothers (Pvt) Ltd., 2014.
Find full text1952-, Norman Richard W., Canadian Medical Association, and Canadian Prostate Health Council, eds. A prostate problem: Benign prostatic hyperplasia : a physician's guide to care and counselling. Montréal: Grosvenor House Press, 1993.
Find full textCunningham, Chet. Your prostate: What every man over 40 needs to know....NOW! 2nd ed. Leucadia, Calif: United Research Publishers, 1992.
Find full textChet, Cunningham, and Chet Cunningham. Your prostate: What every man over 40 needs to know-- now! Leucadia, Calif: United Research Publishers, 1990.
Find full textKathleen, Doheny, ed. The well-informed patient's guide to prostate problems. New York: Dell, 1993.
Find full textH, Schröder F., ed. Recent advances in prostate cancer and BPH: The proceedings of the IV Congress on Progress and Controversies in Oncological Urology (PACIOU IV), held in Rotterdam, the Netherlands, April 1996. New York: Parthenon, 1997.
Find full textKyoichi, Imai, Shimazaki Jun, and Karr James P, eds. Fundamental approaches to the diagnosis & treatment for prostate cancer and BPH: Proceedings of the Fifth Tokyo Symposium on Prostate Cancer, December 16-17, 1993, Keidanren-Kaikan, Tokyo, Japan. Schenectady, NY, USA: Adenine Press, 1994.
Find full textHonma, Yukio. Subete wakaru!! zenritsusen gan, hidaishō. Tōkyō: Mainichi Shinbunsha, 2005.
Find full textShe hu xian fei da. Taibei Xian Shenkeng Xiang: Yuan lu shu she, 2010.
Find full textParker, Philip M., and James N. Parker. Enlarged prostate: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.
Find full textBook chapters on the topic "Prostate – Hypertrophy"
Order, Stanley E., and Sarah S. Donaldson. "Benign Prostate Hypertrophy." In Radiation Therapy of Benign Diseases, 44. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-58719-1_23.
Full textHoffman, Robert M. "Clinical Usefulness of the Histoculture Drug Response Assay for Prostate Cancer and Benign Prostate Hypertrophy (BPH)." In 3D Sponge-Matrix Histoculture, 101–7. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7745-1_11.
Full textScattoni, Vincenzo, and Carmen Maccagnano. "Benign Prostatic Hypertrophy." In Atlas of Ultrasonography in Urology, Andrology, and Nephrology, 281–91. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-40782-1_23.
Full textMebust, W. K. "Benign Prostatic Hypertrophy: Standards and Guidelines." In Alternate Methods in the Treatment of Benign Prostatic Hyperplasia, 26–44. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-45723-4_3.
Full textSullivan, M. P., and S. V. Yalla. "Urodynamic Assessment of Benign Prostatic Hypertrophy." In Alternate Methods in the Treatment of Benign Prostatic Hyperplasia, 66–89. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-45723-4_5.
Full textStone, N. N. "Flutamide and Aromatase Inhibitors in Benign Prostatic Hypertrophy." In Alternate Methods in the Treatment of Benign Prostatic Hyperplasia, 183–93. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-45723-4_12.
Full textLomas, Derek J., and Amy Krambeck. "Surgical management of lower urinary tract symptoms secondary to benign prostatic hypertrophy." In Evidence-Based Urology, 527–37. Chichester, UK: John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119129875.ch46.
Full textSimon, Chantal, Hazel Everitt, Françoise van Dorp, and Matt Burkes. "Renal medicine and urology." In Oxford Handbook of General Practice, 435–70. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199671038.003.0014.
Full textShaw, Aidan, Irfan Ahmed, and Tarun Sabharwal. "Prostate artery embolization for benign prostate hypertrophy." In Challenging Concepts in Interventional Radiology and Endovascular Procedures, 195–200. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199664382.003.0023.
Full text"PROSTATIC HYPERTROPHY AND CANCER OF THE PROSTATE." In General Practice for Lawyers, 209–16. Routledge-Cavendish, 1996. http://dx.doi.org/10.4324/9781843143604-24.
Full textConference papers on the topic "Prostate – Hypertrophy"
Gomella, Leonard G., M. A. Lotfi, Douglas F. Milam, David Albala, and Gary Reagan. "Contact laser vaporization of the prostate for benign prostatic hypertrophy." In OE/LASE '94, edited by Graham M. Watson, Rudolf W. Steiner, and Douglas E. Johnson. SPIE, 1994. http://dx.doi.org/10.1117/12.175023.
Full textWalendziuk, Wojciech, Aleksander Sawicki, and Adam Idźkowski. "The supporting method for automatic diagnosis of prostatic hypertrophy." In Biomdlore. VGTU Technika, 2016. http://dx.doi.org/10.3846/biomdlore.2016.13.
Full textMuschter, Rolf, Alfons G. Hofstetter, Stefan F. F. Hessel, Ernst Keiditsch, Karl-Heinz Rothenberger, Peter Schneede, and Klaus H. Frank. "Hi-tech of the prostate: interstitial laser coagulation of benign prostatic hypertrophy." In OE/LASE '92, edited by R. R. Anderson. SPIE, 1992. http://dx.doi.org/10.1117/12.137385.
Full textWu, Jianchun, and David L. Crowe. "Abstract 1464: Telomere DNA damage links benign prostatic hypertrophy, intraepithelial neoplasia, and prostate cancer." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-1464.
Full textTanaka, Mami, Mitsuyuki Furubayashi, Yoshikatsu Tanahashi, and Seiji Chonan. "Active palpation sensor for detecting prostatic cancer and hypertrophy." In Smart Materials and MEMS, edited by Dinesh K. Sood, Ronald A. Lawes, and Vasundara V. Varadan. SPIE, 2001. http://dx.doi.org/10.1117/12.420885.
Full text